Principal Investigator
Frances Valdes
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20250426
Clinical Trial Summary
A PHASE 1B/2, OPEN-LABEL, MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER.
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647